Advanced 7T fMRI for brain function in epilepsy and brain injuries
Official title: Advanced Space-time Resolved Techniques for fUnctional neuROimaging Characterization of Structurally Abnormal Eloquent coRtical Areas
Run by Imago 7 Fondazione di Ricerca onlus · NCT07865546 · Data updated 2026-11-12
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 65 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Imago 7 Fondazione di Ricerca onlus Academic / other |
| Locations | 1 site (Pisa, Italy) |
| Status | Recruiting |
| Started | October 16, 2024 |
| Main results expected | October 16, 2027 |
| Study ends | October 16, 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07865546 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with drug-resistant epilepsy or individuals with pre-, peri-, or post-natal brain lesions, able to complete 7T fMRI and consent in Italian; healthy volunteers aged 18+ for comparative imaging.
✕Probably not a fit
Patients may not experience direct therapeutic benefit; some may have limited access to surgical decisions based on 7T imaging results.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project aims to develop and optimize advanced 7T MRI and fMRI techniques to improve image quality and temporal resolution using deep learning and real-time field monitoring. It includes functional neuroimaging to study brain function and networks, potentially aiding personalized diagnostics. The study will involve healthy volunteers and patients with drug-resistant epilepsy or brain lesions who may be candidates for surgical treatment, using strict Italian-language informed consent and assent as appropriate. This work builds on prior evidence that 7T MRI can reveal epileptogenic areas and subcortical functional specializations with greater detail than lower-field systems.
Why it matters
Potential benefit: If successful, participants could receive more precise brain maps that help guide diagnosis and treatment planning, including surgical decisions for epilepsy.
How similar studies have gone: Previous work with ultra-high-field MRI has improved detection of epileptogenic regions and functional delineation, though 7T fMRI remains a specialized and evolving area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria Healthy Volunteers * Age ≥ 18 years; * No history of diagnosed psychiatric disorders; * Sufficient understanding of the Italian language (required both for informed consent and for comprehension of fMRI task instructions); * Provision of written informed consent. Patients * Age 6-65 years; * Diagnosis of drug-resistant epilepsy (PMID: 19889013), with or without structural brain abnormalities, and candidate for surgical treatment (PMID: 21145290, 24497269, 31876960), or presence of pre-, peri-, or post-natal brain lesions documented by prior brain MRI; * Normal intellectual functioning or mild cognitive impairment sufficient to ensure adequate collaboration during the 7T functional neuroimaging study; * Sufficient understanding of the Italian language (required both for informed consent and comprehension of fMRI task instructions); * Provision of written informed consent (and assent when applicable, according to age and regulations). Exclusion Criteria (All Participants) * Contraindications to 7T MRI; * Neuropsychiatric comorbidities preventing adequate collaboration during functional neuroimaging; * Pregnancy; * Refusal to receive information regarding incidental findings identified during MRI examination.
Where it's running
-
Imago7 Foundation
Pisa, Italy, Italy Recruiting
Study contacts
- Study coordinator: gilda gallucci
- Email: gilda.gallucci@fsm.unipi.it
- Phone: 0039 050886233
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Nurse-led stigma-reduction education for adults with epilepsy
This trial tests whether a nurse-led education program can reduce internalized stigma and improve self-management for adults with epilepsy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.